Therapeutic Antibody Discovery and Development Services
Your Fast Track from Idea to IND Filing
Advance your therapeutic antibody programs from concept to IND filing with our comprehensive, end-to-end antibody discovery and development solutions. Our services are designed for monoclonal, bi- and multi-specific as well as research and diagnostic antibodies.
Integrated Therapeutic Antibody Discovery
Utilize our phage display and hybridoma technologies to discover novel antibody candidates. Our expertise in antibody humanization, affinity maturation, and Fc engineering enables the generation of potent candidates with minimized immunogenicity risk.
Antibody Generation Services
Access a suite of services including transient and stable expression with the option of a high-throughput workflow, followed by in-depth characterization using advanced biophysical, mass spectrometry, and structural biology techniques.
Antibody in vitro Screening and in vivo Evaluation
Leverage over 4,000 validated assays and animal disease models to assess the mode of action and biological activity, supported by integrated bioanalysis for reliable PK/PD studies.
Streamlined IND-Enabling Package
Our integrated antibody discovery pathway combines antibody production (non-GMP and GMP), pharmacology, GLP toxicology, and regulatory affairs support to ensure a smooth and efficient progression from preclinical candidate to IND submission in as little as 12 months.
Download the brochure to explore case studies and learn how our integrated therapeutic antibody discovery and development services can help you succeed.